Business Context and Reporting Period
This Form 8-K is filed by NanoVibronix, Inc. (trading symbol: NAOV) on November 20, 2023. The report addresses a specific corporate governance event regarding the company's listing status on the Nasdaq Capital Market. Note: The request metadata references "Envue Medical, Inc.," but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, or margin data. The only financial metric disclosed is historical stockholders' equity:
- Stockholders' Equity (as of March 31, 2023): Approximately $2.2 million.
- Nasdaq Minimum Requirement: $2.5 million.
The filing confirms that as of November 20, 2023, the company has met the criteria for continued listing, implying the equity requirement has been satisfied, though the specific current equity value is not stated in the text.
Material Changes
The primary material change is the resolution of a listing deficiency:
- Previous Status: On May 23, 2023, Nasdaq notified the company of non-compliance with Listing Rule 5550(b)(1) due to stockholders' equity falling below the $2.5 million threshold.
- Current Status: On November 20, 2023, Nasdaq confirmed the company's compliance with all applicable criteria, including the minimum stockholders' equity requirement.
- Outcome: The previously announced listing matter has been officially closed.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future operations. The primary risk addressed was the potential delisting from the Nasdaq Capital Market, which has been mitigated by the confirmation of compliance. A press release dated November 21, 2023, is attached as Exhibit 99.1.
Investor Verification Checklist
- Verify the current stockholders' equity value in the most recent 10-Q or 10-K to confirm the specific amount that restored compliance.
- Review the attached press release (Exhibit 99.1) for any additional details on how the equity threshold was met (e.g., capital raise, asset revaluation).
- Confirm the company's ongoing compliance with other Nasdaq listing standards, such as market value of listed securities or net income requirements.